FR2684553B1 - Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee. - Google Patents

Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.

Info

Publication number
FR2684553B1
FR2684553B1 FR9115290A FR9115290A FR2684553B1 FR 2684553 B1 FR2684553 B1 FR 2684553B1 FR 9115290 A FR9115290 A FR 9115290A FR 9115290 A FR9115290 A FR 9115290A FR 2684553 B1 FR2684553 B1 FR 2684553B1
Authority
FR
France
Prior art keywords
hydrosoded
retention
treatment
general
arterial hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9115290A
Other languages
English (en)
Other versions
FR2684553A1 (fr
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioprojet SC
Original Assignee
Bioprojet SC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet SC filed Critical Bioprojet SC
Priority to FR9115290A priority Critical patent/FR2684553B1/fr
Priority to JP5510661A priority patent/JPH06507180A/ja
Priority to PCT/FR1992/001162 priority patent/WO1993011797A1/fr
Publication of FR2684553A1 publication Critical patent/FR2684553A1/fr
Application granted granted Critical
Publication of FR2684553B1 publication Critical patent/FR2684553B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9115290A 1991-12-10 1991-12-10 Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee. Expired - Fee Related FR2684553B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9115290A FR2684553B1 (fr) 1991-12-10 1991-12-10 Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
JP5510661A JPH06507180A (ja) 1991-12-10 1992-12-09 アトリオペプチダーゼ阻害剤と少なくとも１つのカルシウム拮抗剤とを含む医薬
PCT/FR1992/001162 WO1993011797A1 (fr) 1991-12-10 1992-12-09 Medicament contenant un inhibiteur de l'atriopeptidase et au moins un antagoniste calcique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115290A FR2684553B1 (fr) 1991-12-10 1991-12-10 Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.

Publications (2)

Publication Number Publication Date
FR2684553A1 FR2684553A1 (fr) 1993-06-11
FR2684553B1 true FR2684553B1 (fr) 1995-04-07

Family

ID=9419867

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9115290A Expired - Fee Related FR2684553B1 (fr) 1991-12-10 1991-12-10 Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.

Country Status (3)

Country Link
JP (1) JPH06507180A (fr)
FR (1) FR2684553B1 (fr)
WO (1) WO1993011797A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3629060A1 (de) * 1986-08-27 1988-03-03 Bayer Ag Kombination von positiv inotrop wirkenden dihydropyridinen mit ace-hemmern, sowie ihre verwendung in arzneimitteln
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2623498B1 (fr) * 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
FR2684553A1 (fr) 1993-06-11
WO1993011797A1 (fr) 1993-06-24
JPH06507180A (ja) 1994-08-11

Similar Documents

Publication Publication Date Title
RU93058536A (ru) Орально вводимая форма лекарственного средства на основе пантопразола
DE68913557D1 (de) Peritonealdialyse-katheter.
DE68905161D1 (de) Den blutcholesterinspiegel senkende arzneimittel.
EP0217206A3 (en) Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
FR2678171B1 (fr) Catheter a ballon pour pompage dans l'aorte.
FR2502499B1 (fr) Appareil pour la retroperfusion sanguine, destine notamment au traitement d'infarctus par injection de sang arteriel dans le sinus coronaire
FR2698780B1 (fr) Catheter pour le traitement d'un tissu pathologique.
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2684877B1 (fr) Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue.
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
FR2554814B1 (fr) Oxazolidines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement de l'obesite et du diabete
FR2674753B1 (fr) Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
FR2684553B1 (fr) Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
NO892764L (no) Medikamentell administreringsform for droevtyggere.
FR2529083B2 (fr) Appareil pour la retroperfusion sanguine, destine notamment au traitement d'infarctus par injection de sang arteriel dans le sinus coronaire
NO891130D0 (no) Doseringspumpesystem.
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.

Legal Events

Date Code Title Description
ST Notification of lapse